Liu Y - Search Results

1

CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.

Song B, Liu Y, Liu J, Song X, Wang Z, Wang M, Zhu Y, Han J. Song B, et al. Among authors: liu j, liu y. Respiration. 2011;82(5):439-44. doi: 10.1159/000329345. Epub 2011 Aug 11. Respiration. 2011. PMID: 21832820

2

Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.

Zhou W, Jiang Z, Liu N, Xu F, Wen P, Liu Y, Zhong W, Song X, Chang X, Zhang X, Wei G, Yu J. Zhou W, et al. Among authors: liu y, liu n. J Cancer Res Clin Oncol. 2009 Jan;135(1):91-102. doi: 10.1007/s00432-008-0435-x. Epub 2008 Aug 1. J Cancer Res Clin Oncol. 2009. PMID: 18670789

3

Preparation study of indocyanine green-rituximab: A new receptor-targeted tracer for sentinel lymph node in breast cancer.

Cong BB, Sun X, Song XR, Liu YB, Zhao T, Cao XS, Qiu PF, Tian CL, Yu JM, Wang YS. Cong BB, et al. Oncotarget. 2016 Jul 26;7(30):47526-47535. doi: 10.18632/oncotarget.10204. Oncotarget. 2016. PMID: 27374088 Free PMC article.

4

Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.

Bi Z, Liu J, Chen P, Liu Y, Zhao T, Wang C, Zhang Z, Sun X, Qiu P, Cong B, Song X, Wang Y. Bi Z, et al. Among authors: liu j, liu y. Breast Cancer. 2019 May;26(3):373-377. doi: 10.1007/s12282-018-00934-3. Epub 2019 Jan 21. Breast Cancer. 2019. PMID: 30666563

5

Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer.

Bi Z, Chen P, Liu YB, Zhao T, Sun X, Song XR, Wang YS. Bi Z, et al. Breast Cancer Res Treat. 2020 Nov;184(2):397-405. doi: 10.1007/s10549-020-05851-8. Epub 2020 Aug 10. Breast Cancer Res Treat. 2020. PMID: 32776291

6

Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer.

Chen P, Zhao T, Bi Z, Zhang ZP, Xie L, Liu YB, Song XG, Song XR, Wang CJ, Wang YS. Chen P, et al. Future Oncol. 2021 Jul;17(19):2449-2460. doi: 10.2217/fon-2020-1231. Epub 2021 Apr 21. Future Oncol. 2021. PMID: 33878939

7

EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations.

Zhou W, Jiang Z, Li X, Xu F, Liu Y, Wen P, Kong L, Hou M, Yu J. Zhou W, et al. Among authors: liu y. J Korean Med Sci. 2009 Feb;24(1):97-103. doi: 10.3346/jkms.2009.24.1.97. Epub 2009 Feb 28. J Korean Med Sci. 2009. PMID: 19270820 Free PMC article.

8

[BRCA1 germ line mutations in Chinese early-onset breast cancer patients].

Li WF, Hu Z, Liu XY, Zhang B, Cao MZ, Wang YS, Zhao L, Liu YB, Yuan WT, Shen ZZ, Huang W, Shao ZM. Li WF, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Oct;24(5):499-504. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007. PMID: 17922413 Chinese.

9

Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients.

Bi X, Wang Y, Li M, Chen P, Zhou Z, Liu Y, Zhao T, Zhang Z, Wang C, Sun X, Qiu P. Bi X, et al. Among authors: liu y. Onco Targets Ther. 2015 Feb 23;8:487-93. doi: 10.2147/OTT.S78903. eCollection 2015. Onco Targets Ther. 2015. PMID: 25750542 Free PMC article.

10

Association between NAT2 polymorphisms and acute leukemia risk: A meta-analysis.

Zhu X, Liu Y, Chen G, Guo Q, Zhang Z, Zhao L, Wei R, Yin X, Zhang Y, Wang B, Li X. Zhu X, et al. Among authors: liu y. Medicine (Baltimore). 2019 Mar;98(12):e14942. doi: 10.1097/MD.0000000000014942. Medicine (Baltimore). 2019. PMID: 30896661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,085 results

Search Page

Filters